v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Jun. 27, 2025
Jun. 28, 2024
Cash flows from operating activities:    
Net Income (Loss) $ (27,674) $ 23,268
Adjustments to reconcile Net Income (Loss) to Net cash provided by operating activities:    
Depreciation and amortization 107,674 105,500
Deferred income taxes (16,002) (10,166)
Share-based compensation expense 11,009 13,303
Asset write-down 189 980
Loss on sale of equity investment, net 2,150 0
(Gain) Loss on disposals of property and equipment (726) 618
Amortization of debt issuance costs 2,662 1,478
Loss on extinguishment of debt 0 3,883
Changes in operating assets and liabilities:    
Receivables, net 1,063 (17,230)
Inventories, net (21,487) 21,136
Rental merchandise in service, net (4,708) 178
Other current assets (11,888) (6,230)
Accounts payable (1,494) 14,471
Accrued expenses and other current liabilities 19,203 54,511
Changes in other noncurrent liabilities (22,718) (16,900)
Changes in other assets (3,879) (10,932)
Other operating activities (72) (1,668)
Net cash provided by operating activities 33,302 176,200
Cash flows from investing activities:    
Purchases of property and equipment and other (43,102) (50,787)
Proceeds from disposals of property and equipment 5,365 0
Proceeds from sale of equity investment 36,792 0
Other investing activities (4,576) 0
Net cash used in investing activities (5,521) (50,787)
Cash flows from financing activities:    
Proceeds from long-term borrowings 93,000 798,000
Payments of long-term borrowings (85,000) (879,500)
Payments of financing lease obligations (25,630) (22,572)
Net cash distributions to Parent 0 (6,051)
Dividend payments (13,822) (9,199)
Debt issuance costs (1,628) (11,134)
Other financing activities (2,037) (1,853)
Net cash used in financing activities (35,117) (132,309)
Effect of foreign exchange rates on cash and cash equivalents 69 (57)
Decrease in cash and cash equivalents (7,267) (6,953)
Cash and cash equivalents, beginning of period 31,010 36,051
Cash and cash equivalents, end of period $ 23,743 $ 29,098

Source

10-Q PDF
XBRL